CEVENFACTA

This brand name is authorized in Austria, Croatia, France, Italy, Lithuania, UK.

Active ingredients

The drug CEVENFACTA contains one active pharmaceutical ingredient (API):

1	Eptacog beta (activated) UNII AC71R787OV - COAGULATION FACTOR VIIA RECOMBINANT HUMAN
	Pharmacological doses of rFVIIa activate factor X directly on the surface of activated platelets, localized to the site of injury, independently of tissue factor. This results in the conversion of prothrombin into large amounts of thrombin independently of tissue factor.
	Read more about Coagulation factor VIIa

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
CEVENFACTA Powder and solvent for solution for injection	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
B02BD08	Eptacog alfa (activated)	B Blood and blood forming organs → B02 Antihemorrhagics → B02B Vitamin K and other hemostatics → B02BD Blood coagulation factors
Discover more medicines within B02BD08

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
FR	Base de données publique des médicaments	67797496, 68117241, 68677884
IT	Agenzia del Farmaco	050298013, 050298025, 050298037
LT	Valstybinė vaistų kontrolės tarnyba	1095406, 1095407, 1095408